Web Images Videos Maps News Shopping Gmail more »
Sign in
Go to Blog Search Home

  
  Advanced Blog Search
  Preferences
 Blog resultsResults 1 - 10 of about 42,283 for chronic leukemia. (0.15 seconds) 
Browse Top Stories
Published
Anytime

Subscribe:
Blogs Alerts Blogs Alerts
Atom | RSS
Sorted by relevance    Sort by date
 
Related Blogs:
Chronic Lymphocytic Leukemia Health News - http://www.medindia.net/healthnews/Chronic-Lymphocytic-Leukemia_news.asp
leukemia symptoms - http://hammeranvil.blogspot.com/

UK's NICE says “no” to Novartis' Afinitor for advanced RCC and ...
23 hours ago
The NICE has also updated its draft guidance on the use of US firm Bristol-Myers-Squibb Sprycel (dasatinib) and Novartis' Tasigna (nilotinib) for chronic myeloid leukemia. Following the previous public consultation and subsequent ...
thepharmaletter.com - http://www.thepharmaletter.com/

NICE says pharma should help pay for leukemia drugs - Medical ...
20 hours ago
In the US, Novartis has launched several websites to help patients cope with chronic myelogenous leukemia (CML), and pay for treatment. MyCMLCircle.com provides information about Gleevec and Tasigna, and lets patients sign up for ...
Latest articles from Medical Marketing and Media - http://www.mmm-online.com/
[ More results from Latest articles from Medical Marketing and Media ]

Optimizing therapy for patients with chronic myelogenous leukemia ...
2 Feb 2010 by rob  
Identification of BCR-ABL as the defining leukemogenic event in chronic myelogenous leukemia (CML) revolutionized the treatment of the disease. Imatinib, a potent BCR-ABL inhibitor, is the standard of care for the first-line treatment ...
CMLHope.Com - http://cmlhope.com/
[ More results from CMLHope.Com ]

Blood -- Many chronic lymphocytic leukemia antibodies recognize ...
28 Jan 2010 by Chu, CC, Catera, R., Zhang, L., Didier,...  
Many B-cell chronic lymphocytic leukemia (CLL) monoclonal antibodies (mAbs) can be grouped into subsets based on nearly identical stereotyped sequences. Subset 6 CLL mAbs recognize non-muscle myosin heavy chain IIA (MYHIIA). ...
BLOOD First Edition Papers - http://bloodjournal.hematologylibrary.org/
[ More results from BLOOD First Edition Papers ]

Bendamustine for the treatment of chronic lymphocytic leukemia and ...
30 Jan 2010 by Dr. Steve  
Bendamustine was approved by the US Food and Drug Administration (FDA) for the treatment of chronic lymphocytic leukemia (CLL) in March 2008 and for the treatment of rituximab-refractory, indolent B-cell non-Hodgkin lymphoma (NHL) in ...
Cancer News Today - http://www.cancernewstoday.com/

Extreme Weather In Washington D.C. Has Postponed The FDA's ...
10 hours ago by admin  
ChemGenex believes in the safety and efficacy of OMAPRO™ for the treatment of patients with chronic myeloid leukemia (CML) who are resistant to imatinib and have the Bcr-Abl T315I mutation. The company is aware of the questions posed by ...
UsHour.com - http://www.ushour.com/

Warning Signs of Leukemia
31 Jan 2010 by kakumei  
The types of leukemia--acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia--are cancers that affect the function of the white blood cells. Learn the warning signs of ...
Medical Science - http://www.brighthub.com/science/medical/articles/33425.aspx

The IN VIVO Blog: "No!" says NICE, to Sprycel, Tasigna
19 hours ago by Melanie Senior  
The UK cost-effectiveness watchdog NICE today delivered a resounding "no" to the use on the National Health Service of Bristol's dasatinib (Sprycel) and Novartis' nilotinib (Tasigna) in chronic myeloid leukemia patients intolerant to ...
The IN VIVO Blog - http://invivoblog.blogspot.com/

Particularities of Different Types of Leukemia | Health Care Change
31 Jan 2010 by admin  
In addition to the common forms of chronic leukemia, there are also some rare types. Hairy cell leukemia (HCL), just like chronic lymphocytic leukemia, has a slow progression. The cells of hairy cell leukemia are different from other ...
Health Care Change - http://www.healthcarechange.org/ - References

Best Choice For Chronic Leukemia Treatment May Change - Science News
8 Dec 2009 by scinews@sciencenews.org (Science News)  
Nilotinib demonstrates superior efficacy compared with imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase: Results from the International Randomized Phase III ENESTnd Trial. Abstract # LBA-1. ...
Latest Science News Features, Blog Entries,... - http://www.sciencenews.org/view/feature/id/41220... - References

Stay up to date on these results:




 
  

Google Home - About Google Blog Search Beta - Information for Blog Authors

©2009 Google